惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Microsoft Azure Blog
Microsoft Azure Blog
aimingoo的专栏
aimingoo的专栏
F
Fortinet All Blogs
Blog — PlanetScale
Blog — PlanetScale
GbyAI
GbyAI
MongoDB | Blog
MongoDB | Blog
月光博客
月光博客
The Cloudflare Blog
量子位
T
Tailwind CSS Blog
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
B
Blog
MyScale Blog
MyScale Blog
T
The Blog of Author Tim Ferriss
The GitHub Blog
The GitHub Blog
G
Google Developers Blog
D
DataBreaches.Net
V
Visual Studio Blog
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
Last Week in AI
Last Week in AI
U
Unit 42
博客园 - 聂微东
有赞技术团队
有赞技术团队
A
About on SuperTechFans

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Hapvida Participações e Investimentos S.A. (HAPVY) Q1 202...
2026-05-16 · via All Articles on Seeking Alpha

Hapvida Participações e Investimentos S.A. (HAPVY) Q1 2026 Earnings Call May 12, 2026 12:00 PM EDT

Company Participants

Luccas Adib
Lucas Garrido
Felipe Nobre

Conference Call Participants

Vinicius Figueiredo - Itaú Corretora de Valores S.A., Research Division
Leandro Bastos - Citigroup Inc., Research Division
Joseph Giordano - JPMorgan Chase & Co, Research Division
Flavio Yoshida - BofA Securities, Research Division
Eduardo Resende - UBS Investment Bank, Research Division
Mauricio Cepeda - Morgan Stanley, Research Division

Presentation

Operator

Hi, everyone. Welcome to Hapvida's First Quarter 2026 Earnings Conference Call. Joining us today are Luccas Adib, CEO; Lucas Garrido, VP of Finance; and Felipe Nobre, VP of Strategy, M&A and IR. [Operator Instructions] This event is being recorded and will be made available on the company's IR website together with the complete earnings materials. You can download the presentation by clicking on the chat icon.

Please be aware of the disclaimers that govern this release at the end of the presentation. [Operator Instructions] I will now turn the floor over to CEO, Luccas Adib, who will begin the presentation. Please proceed, sir.

Luccas Adib

Hi, everyone. Good morning. Thank you for joining us for another one of our earnings conference calls. In our last conference, I thanked Dr. Cande, Jorge, and Candido Junior, Hapvida's controlling family who have now become majority shareholders after once again doubling down on the company as recently disclosed. On this call, I'd like to start with a few brief acknowledgments. I'll start with our newly elected Board of Directors and thank them for the trust placed in me to become Hapvida's CEO.

I take on this role with honor and humility and a deep sense of duty, discipline and commitment to our noble mission, providing health care to over 15 million Brazilians we serve every day. I also want to thank our new Board